Suppr超能文献

BMIPP的未来展望。

Future aspects of BMIPP.

作者信息

Tamaki N, Morita K, Tsukamoto E, Kawai Y

机构信息

Department of Nuclear Medicine, Hokkaido University School of Medicine, Sapporo, Japan.

出版信息

Int J Card Imaging. 1999 Feb;15(1):79-89. doi: 10.1023/a:1006109022417.

Abstract

Iodinated fatty acid compounds have an important role in early detection of myocardial abnormalities and provide insights into pathological states in the heart. Among them, 15-(p-iodophenyl)-3R,S-methyl pentadecanoic acid (BMIPP) has been most widely used providing excellent images of the left ventricular myocardium due to high myocardial uptake and long retention. The previous chapters have focused on the basic characters and clinical applications of this compound. However, the precise mechanisms of myocardial kinetics should be further investigated under various conditions. Most of the studies showed reduced BMIPP uptake relative to perfusion in a variety of myocardial disorders, whereas an increase in BMIPP uptake relative to perfusion is often reported. The potential mechanisms of such conflicting results are discussed, but basic studies should be performed to clarify such results in detail. There are a number of clinical values of this compound. Since alteration of fatty acid is observed in the repetitive ischemia, BMIPP can be used for detecting severe ischemic episodes. The concept of 'ischemic memory' imaging can be applied for patients with unstable or vasospastic angina at rest and for those with acute myocardial infarction with successful revascularization to identify the risk area. The discordant decrease in BMIPP uptake relative to perfusion is often seen in ischemic but viable myocardium, and therefore, the combined imaging of BMIPP and perfusion can be used for assessment of tissue viability. Furthermore, abnormal BMIPP uptake is most often observed in hypertrophic cardiomyopathy, and thus, this compound can be used for an early detection and differential diagnosis of the cardiomyopathy. Although BMIPP imaging seems to be quite promising in many fields, the number of patient data remain limited. In this respect, a multicenter study with a vast majority of patients is warranted to confirm these important values of BMIPP. In addition, this attractive tracer should be available all over the world to confirm its clinical value in the near future.

摘要

碘化脂肪酸化合物在心肌异常的早期检测中具有重要作用,并能为心脏的病理状态提供深入了解。其中,15-(对碘苯基)-3R,S-甲基十五烷酸(BMIPP)由于心肌摄取率高且滞留时间长,已被最广泛地用于提供左心室心肌的优质图像。前面的章节重点介绍了该化合物的基本特性和临床应用。然而,心肌动力学的精确机制在各种条件下仍需进一步研究。大多数研究表明,在多种心肌疾病中,相对于灌注,BMIPP摄取减少,而相对于灌注,BMIPP摄取增加的情况也经常被报道。虽然讨论了这些相互矛盾结果的潜在机制,但仍应进行基础研究以详细阐明这些结果。该化合物具有许多临床价值。由于在重复性缺血中观察到脂肪酸的改变,BMIPP可用于检测严重缺血发作。“缺血记忆”成像的概念可应用于静息时不稳定或血管痉挛性心绞痛的患者以及成功进行血管重建的急性心肌梗死患者,以识别风险区域。在缺血但仍存活的心肌中,经常可以看到相对于灌注,BMIPP摄取不一致地减少,因此,BMIPP与灌注的联合成像可用于评估组织活力。此外,肥厚型心肌病中最常观察到BMIPP摄取异常,因此,该化合物可用于心肌病的早期检测和鉴别诊断。尽管BMIPP成像在许多领域似乎很有前景,但患者数据的数量仍然有限。在这方面,有必要进行一项包含绝大多数患者的多中心研究,以证实BMIPP的这些重要价值。此外,这种有吸引力的示踪剂应在全球范围内可用,以便在不久的将来证实其临床价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验